Category: News

  • Robbery Escalates Into Shooting at Cordova Smoke Shop; Man Charged With Attempted Murder

    MEMPHIS, Tenn. (WMC) — An 18-year-old, Marquis Davis, has been charged with attempted first-degree murder after a Halloween robbery at a smoke shop on North Germantown Parkway turned into a shooting.

    Shelby County Jail records show Davis was formally charged Sunday. Booking records indicate he remained in the hospital emergency room Monday night after being shot by law enforcement.

    Davis faces counts of attempted first-degree murder, aggravated robbery and employment of a firearm during the commission of a dangerous felony.

    The Tennessee Bureau of Investigation says Davis robbed employees at the Exotic Smoke Shop in the Dexter Ridge Shopping Center Friday afternoon. While inside, he allegedly shot a woman and then ran from the store; witnesses said he fled with cash.

    Officers with the Memphis Safe Task Force were eating at a nearby restaurant when they received the call and pursued Davis. Witnesses reported he fired additional shots as officers intervened. TBI says officers shot Davis before detaining him.

    Memphis police say the woman shot inside the smoke shop was rushed to the hospital in critical condition. The extent of Davis’ injuries has not been released. Bail and hearing information are not available at this time.

    Copyright 2025 WMC. All rights reserved.


    This article was adapted from an original report published on actionnews5.com. All rights belong to the original publisher.

  • 9-Year-Old Fighting for Life After Antioch Smoke Shop Shooting

    9-year-old in critical condition after shooting at Antioch smoke shop


    This article was adapted from an original report published on sfchronicle.com. All rights belong to the original publisher.

  • PMI Announces Major Organizational Overhaul Set for 2026

    Philip Morris International unveiled the details of a streamlined organizational structure designed to accelerate its shift toward a smoke-free future. The company will consolidate into two main business units—PMI International and PMI U.S.—and a wellness division, Aspeya; all three will report directly to CEO Jacek Olczak.

    The existing four geographic segments will be replaced by three reportable segments: International Smoke‑Free, International Combustibles, and U.S. PMI says financial reporting under the new structure will begin in Q1 2026, and the changes take effect January 1, 2026.

    First disclosed alongside its third‑quarter financials, the leadership lineup names Frederic de Wilde as CEO of PMI International, while Stacey Kennedy will continue as CEO of PMI U.S.

    The reorganization underscores PMI’s emphasis on expanding smoke‑free alternatives—which now make up 41% of the company’s net revenues—while continuing to grow its combustibles business and pursue opportunities in wellness and healthcare.


    This article was adapted from an original report published on tobaccoreporter.com. All rights belong to the original publisher.

  • Board of Health Refuses to Shut Down Vape Shop

    LYNN — Five months after an inspection turned up flavored vape products at Jolly Vapors, the Board of Health voted not to close the shop.

    On May 23, Ordinance Enforcement Officer Christopher Poole inspected 104 Woodman St. and discovered “thousands” of flavored vape items stored in a box in a back room. The sale of flavored vape products at retail stores has been banned in Massachusetts since 2020, and the Board considered whether the finding warranted revoking the store’s tobacco license.

    Owner Jack Jolly and attorney Sam Vitali told the Board the portion of the building where the products were found had been leased to an unaffiliated tenant, Eric Schwarz, a licensed tobacco distributor in New Hampshire who was using the room for storage.

    Board member Dr. Clark Van Den Berghe called the circumstances “really suspicious,” but said there wasn’t enough evidence directly linking Jolly to the contraband to justify shutting the shop down. “We’re not a court of law. If we look at the facts, I don’t think we’d be able to stand and say we have proof that he is doing this. So I don’t feel comfortable suspending it, but he’s on pretty thin ice,” he said at the Oct. 21 meeting.

    Chairman Ron Dupuis expressed a similar view before the Board unanimously voted against revoking Jolly Vapors’ license. “This isn’t about giving anybody a chance or not giving anybody a chance. It’s about if you violate the law to a great enough amount for us to have to take away your permit. I’m not sure that this rises to that occasion. If we take it away and go to court, we’re going to lose because there’s not enough proof,” Dupuis said. He added that while the Board must protect public health from egregious business practices, it also must be certain before stripping someone of their permit: “If we’re going to take that away, I think we have to be 100% clear. I don’t feel comfortable permanently suspending it either.”

    Jolly Vapors has remained closed at the Woodman Street location since May after an unrelated shooting in the neighborhood raised safety concerns. New zoning rules also require a tobacco retailer seeking to open at a new site to obtain City Council approval for a special permit, because tobacco stores are classified as “sensitive retail.”

    Jolly said he has looked for a new location since May but hesitated to finalize any options while his license was at risk. “I’m glad they didn’t revoke my license. They didn’t have sufficient evidence. But it’s been a struggle to find a new location. It’s not going to be easy,” he said.


    This article was adapted from an original report published on itemlive.com. All rights belong to the original publisher.

  • Universal Set to Reveal Q2 Fiscal 2026 Results

    Universal Corporation will release its second-quarter fiscal 2026 results after the market close on November 5. A listen-only conference call is scheduled for 10 a.m. ET on November 6 and will be webcast live at www.universalcorp.com. A replay of the call will be available through February 6, 2026.


    This article was adapted from an original report published on tobaccoreporter.com. All rights belong to the original publisher.

  • ‘Trump Effect’ Fuels Hopes for Cannabis Rally as Investors Bet on Federal Reforms and a Softer Marijuana Stance

    Cannabis stocks may be on the brink of a comeback after years of little movement, driven by investor hope for new federal rules on hemp-derived products and signs that President Donald Trump could take a more permissive approach to marijuana. Publicly traded cannabis companies have experienced mixed results. Verano Holdings on Wednesday reported $203 million in revenue — a small increase from the prior quarter but down 6% year-over-year — and a $44 million net loss that included a $5 million impairment on a Pennsylvania facility and $10 million in legal contingencies tied to a settlement. Curaleaf and Trulieve are scheduled to report earnings next week. While cannabis-focused ETFs are down roughly 10% this year, some executives remain upbeat. Tilray Brands’ CEO Irwin Simon said the industry could be at an “inflection point,” noting Tilray’s stock jumped 22% in October after better-than-expected fiscal first-quarter results. “If reforms move forward, it could attract more companies to do business in the U.S.,” Simon told CNBC.

    Three developments are fueling the optimism: Trump’s apparent support for Medicare coverage of CBD (a non-intoxicating hemp compound), his comments about reclassifying marijuana’s drug status, and congressional moves to regulate hemp. Cannabis use is also rising. A 2024 report analyzing 40 years of data from Carnegie Mellon University found daily or near-daily marijuana use has surpassed daily drinking in the U.S. The Department of Agriculture says the annual value of U.S. cannabis production grew 40% last year. And Grand View Research projects cannabis-derived products, including CBD and marijuana-based items, could become a $160 billion global market by 2032.

    The so-called “Trump effect” kicked in when the president shared a video on Truth Social in September promoting Medicare coverage for CBD and making unproven anti-aging claims. The video, produced by The Commonwealth Project — an advocacy group for seniors using cannabis founded and funded by billionaire Howard Kessler — directly appealed to Trump. Kessler, who moved into cannabis advocacy after a career in affinity credit cards, has been in Trump’s orbit for years. Neither Kessler nor the White House responded to requests for comment. Markets reacted quickly: on the day the video was posted, Tilray shares jumped 42%, Aurora Cannabis gained 25%, Canopy Growth rose 18%, and Cronos Group added 15.5%. “A lot of folks in the industry saw him posting the video as a bit of a surprise but we think he’s trying to gauge how the public feels about cannabis products,” said Adam Smith, executive director of the Marijuana Policy Project. Critics urged caution. Kevin Sabet of Smart Approaches to Marijuana said it’s premature to view the posts as a full endorsement of reform, noting social posts don’t always reflect formal policy. And experts point out limited evidence on effective CBD doses for inflammation or chronic pain, especially in seniors; to date the FDA has approved only one CBD-based drug, Epidiolex. “Other uses lack scientific evidence and have largely unknown effects,” said Meg Haney, director of the Cannabis Research Laboratory at Columbia University.

    Discussion about CBD ties into a broader push to update the 2018 Farm Bill, which legalized hemp (the low-THC variant of the marijuana plant). Congress is considering updates by year’s end that could set federal standards for labeling, testing and safety for hemp-derived products that the original law left unregulated. “Regulation isn’t scary, as long as it is effective, because the clearer the lines are, the better it is to be in the business [when] you don’t have a looming axe over your head,” said Pamela Epstein, chief legal and regulatory officer at hemp producer Terpene Belt Farms. The 2018 law helped create a market the data firm Grand View Research valued at $1.6 billion by 2023. Hemp-derived CBD products with under 0.3% THC spread into gummies, drinks, creams and pet treats, and are projected to drive more than 20% growth by 2030. But without federal oversight, some consumers encountered mislabeled, untested and unsafe products. “It’s possible the hemp sector grew a little too fast without rules,” Smith said, citing high-THC products marketed as CBD, items aimed at children, and tainted samples. Congressional proposals range from outright bans to tighter THC limits; some in the industry want an “alcohol-model” framework with the FDA overseeing safety and the Alcohol and Tobacco Tax and Trade Bureau handling taxation and distribution. “Clear rules aren’t scary,” Simon said. “They’re the best way to grow sustainably and shed the uncertainty that’s defined this space for years.” Industry groups warn that a ban could cripple an economy that supports roughly 320,000 jobs, according to the U.S. Hemp Roundtable. Michael Mayes, CEO of consulting firm Quantum 9, argued federal standards are essential to legitimize the market and attract institutional investors. “Smart, consistent rules could be the key to unlocking billions in growth while working to ensure consumer safety,” Mayes told CNBC.

    Trump’s apparent openness to CBD has also prompted speculation he might go further. In August he said his administration was “looking at” reclassifying marijuana from a Schedule I drug to Schedule III — a change that wouldn’t legalize recreational use but could make it easier to sell, ease banking and tax restrictions, and remove obstacles to scientific research. “To demonstrate that cannabis has medical utility, we need to do large, controlled trials, but we can’t really do those if it’s a Schedule I drug,” Haney said. “As a result, that means you can’t do the studies needed to reschedule it. It’s like the chicken and egg conundrum.” A White House official said the rescheduling process is ongoing and that “all policy and legal requirements and implications are being considered.” Industry optimism has also focused on Trump’s chief of staff, Susie Wiles, who previously worked at a Florida lobbying firm that represented Trulieve, one of the largest U.S. cannabis companies, and is described by multiple industry sources as a close friend of Trulieve CEO Kim Rivers. Trulieve reportedly spent more than $100 million backing a failed ballot measure to legalize recreational cannabis in Florida, and federal filings show it donated $750,000 to Trump’s inauguration committee and $250,000 to his MAGA Inc. super PAC. Rivers attended pre-inauguration events and reportedly joined a $1 million-a-plate fundraiser at Trump’s New Jersey golf club in August, where she urged the president to reclassify marijuana; two days later, Trump made his “looking at” comments. Wiles, Rivers and Trulieve did not respond to requests for comment.

    Republican roadblocks


    This article was adapted from an original report published on cnbc.com. All rights belong to the original publisher.

  • Maldives Makes History With First-Ever Generational Tobacco Ban

    The Maldivian government has passed landmark amendments to its Tobacco Control Act, creating a generational ban on tobacco use. Effective immediately, anyone born on or after January 1, 2007, is prohibited from using tobacco. At the same time, vendors are forbidden from selling tobacco to anyone under 21 or to those covered by the generational cutoff.

    With the changes, the Maldives becomes the first country in the world to permanently bar an entire generation from smoking. The law also establishes a nationwide ban on electronic cigarettes and vaping products — covering their use, possession, importation, and manufacture.

    President Mohamed Muizzu said the measures reflect his vision of fostering a “competent, morally upright, and diligent citizenry.”


    This article was adapted from an original report published on tobaccoreporter.com. All rights belong to the original publisher.

  • Omaha Tribe Moves Forward on Marijuana Plan, Accuses Nebraska AG of ‘Retaliation’ in Tobacco Tax Talks

    LINCOLN — The Omaha Tribe of Nebraska has moved forward with legalizing marijuana, a step its attorney general says prompted state officials to halt talks on an unrelated tobacco tax compact — a move the tribe calls “direct retaliation.”

    Omaha Tribe Attorney General John Cartier said an assistant state attorney general called him Monday, roughly an hour before the tribe’s first cannabis commission meeting, to say state negotiators would no longer pursue a tobacco tax compact because the tribe had taken a more permissive stance on cannabis. The tribe’s council unanimously voted in July to legalize medical cannabis and adult-use marijuana; the new commission’s initial focus, Cartier said, is strictly medical cannabis.

    “It made me pause for about 30 seconds,” Cartier told the Nebraska Examiner. “I wasn’t really anticipating that level of obstruction. I at least appreciated the candor and upfrontness about it.”

    If approved, a tobacco tax compact would allow the state and tribe to split tax revenues from tobacco sales on the reservation — potentially a windfall of hundreds of thousands of dollars for the tribe. The Omaha reservation covers more than 300 square miles in northeast Nebraska, primarily in Thurston County and parts of Burt and Cuming counties.

    Cartier said he later spoke with Nebraska Attorney General Mike Hilgers, who indicated his office would confirm the state’s official position and how Gov. Jim Pillen wanted to proceed. Pillen asked Hilgers this summer to negotiate the compact on the state’s behalf. Hilgers’ office declined to comment on compact negotiations, and Pillen’s office did not respond to questions this week.

    Cartier said he does not expect state policy to change because, in his view, “none of them fundamentally believe in a cannabis industry.” He added that the AG’s Office has signaled plans to spend more tax dollars on policing the tribe’s borders because of the new tribal law.

    “If that is their official stance, in our opinion, that’s direct retaliation, potentially a legal way for them to skirt their responsibilities and to use this as leverage,” Cartier said. He urged the state to honor voters’ decision on medical cannabis, saying, “People need to understand that they are still fighting bitterly to the very end on this topic, even though I think Nebraska voters have spoken.”

    Voters in November 2024 approved measures allowing possession of up to five ounces of medical cannabis with a physician’s recommendation and creating a state commission to regulate medical cannabis. The state’s rules would ultimately permit patients to buy medical cannabis in Nebraska, likely not until at least mid-2026. Hilgers has argued cannabis should remain illegal because it is classified federally as a Schedule I drug, though advocates have long pushed for rescheduling. Congress has repeatedly barred the U.S. Department of Justice from interfering with state medical cannabis programs, and supporters point to the Tenth Amendment when asserting states’ rights to legalize marijuana.

    “I think two plus two is four, even if everyone else says two plus two is five,” Hilgers said in May, reflecting his stance that federal classification should guide state policy. Pillen has said he supports medical marijuana but wants strict regulation to prevent a slide toward recreational legalization.

    Cartier said the Omaha Tribe first approached Pillen in July to open negotiations on a tobacco tax compact. The Santee Sioux Nation has a compact that allows it to retain 75% of tobacco tax revenues; the Omaha Tribe sought to retain 90% while taking on additional regulatory responsibilities from the state, subject to negotiations. State and tribal officials met in August; Cartier described that meeting as “highly productive” and said the state promised a counterproposal within weeks — a promise he says was later withdrawn.

    “After months and months of promises and negotiations to be taken away from us at the last minute, it really is unconscionable to me,” Cartier said. He characterized the state’s response as another episode of government punishment of Native Americans “for just existing,” and said the tribe is pursuing policies that could yield millions in economic development and job opportunities without relying on the federal government.

    On Monday the Omaha Tribe swore in four members of its cannabis commission — Jayzon Hundley, Amanda Hallowell, Arthur Isagholian and Allison Stockman — with Cartier sitting as a nonvoting member. Hundley, the tribe’s grant accountant, and Hallowell, a registered nurse, are enrolled members of the Omaha Tribe. Isagholian has a background in agriculture; Stockman has experience in public safety and public health. Together, the commission members bring roughly 40 years of experience in the cannabis sector from other states. The tribe may seat one additional member.

    Council Chair Jason Sheridan, who noted that many council members know someone who could benefit from medical marijuana, praised the commission. “I have nothing but confidence in all of you,” Sheridan told the new commissioners. Council Secretary Cheyenne Robinson called the swearing-in a “historic day,” saying the tribe is committing to sovereignty, responsible regulation and economic diversification.

    At its inaugural meeting the commission discussed drafting rules and regulations, focusing on product safety testing and how to operate amid a potentially antagonistic state. One option under consideration is testing products on the reservation. Cartier warned commissioners that even if the tribe believes it has legal authority, the state — and specifically the AG’s Office — is “probably more than willing to fight that in the courts.” He said the tribe will defend its sovereignty and laws when necessary. The commission is scheduled to meet next on Nov. 19, when it could vote to approve its rules.

    The tribe’s plan stands in contrast to the Nebraska Medical Cannabis Commission’s near-final state rules, which have been criticized by the public as overly restrictive. Proposed state limits include allowing no more than 12 dispensaries statewide; requiring patients to receive a recommendation from a physician registered with the state program; banning smokable products, vapes, edibles and raw flower in dispensaries; and limiting purchases to no more than 5 grams of delta-9 THC every 90 days. The state commission could finalize its regulations and seek approval from Hilgers and Pillen as soon as Monday.

    Cartier said the Omaha Tribe aims to offer a “stark contrast” to the state rules and to promote access to medical cannabis. “We made a determination that now is a good point to bring this to the public, without waiting for a response from Attorney General Hilgers and the governor, because, in our perspective, we are not in the backseat on this,” he said. “We’re in the driver’s seat, and we want to maintain that position.”


    This article was adapted from an original report published on yahoo.com. All rights belong to the original publisher.

  • Vaping vs. Smoking: Is It Less Harmful — and Can It Really Help People Quit?

    A decade ago, most smokers believed vaping was less harmful than cigarettes. Today, the opposite is true: a majority now say vapes are as dangerous or worse. That shift is visible in survey data and reflects a large change in public conversation about e-cigarettes.

    Why has opinion turned negative? Partly because the headlines have been alarming. Partly because vaping has become far more common and visible — the smell of tobacco in public places has been largely replaced by fruity vape scents. In the UK nearly as many people vape as smoke, about one in ten adults, and vaping has risen fast while smoking fell dramatically over the last few decades.

    Is that a good thing? Or are people swapping one harmful habit for another? Below I answer the most common questions about vaping: how its health risks compare to smoking, whether it helps people quit, whether it’s a gateway to smoking for young people, and other frequent concerns.

    How do the health risks of vaping compare to cigarettes?

    This is the central question. If vaping were just as bad as smoking, replacing cigarettes with e-cigarettes would not improve health. The best available evidence, however, indicates vaping is substantially less harmful than smoking — though not risk-free.

    When you burn a cigarette, combustion produces thousands of chemicals, many toxic or carcinogenic: tar, carbon monoxide, benzene, cadmium, polycyclic aromatic hydrocarbons, and more. Smoking raises the risk of lung cancer, stroke, heart disease and a range of other illnesses. In the UK, smoking is the leading risk factor for early death.

    E-cigarettes work differently. They heat a liquid to produce an aerosol rather than burning tobacco, so far fewer harmful toxins are generated. Many vapes do contain nicotine, which is addictive and can affect heart rate and blood pressure, and is not recommended in pregnancy. Vapes also include solvents, flavorings and small amounts of metals from coils — these can irritate the lungs or worsen conditions like asthma — but overall the exposure to the most dangerous chemicals found in cigarette smoke is much lower.

    We don’t have decades of long-term epidemiological data on vaping the way we do for smoking, but e-cigarettes have been widely used for around 20 years. If vaping produced harms anywhere near those of smoking, we would expect to see clearer warning signs by now. Given what we know about ingredients and exposure, major public health bodies generally conclude vaping is much less harmful than smoking. They advise against vaping for young people and non-smokers, but recommend e-cigarettes as a quitting aid for smokers.

    A concise summary: “If you smoke, vaping is much safer; if you don’t smoke, don’t vape.” — Chris Whitty, Chief Medical Officer for England

    Do vapes deliver more nicotine than cigarettes?

    There’s a common claim that a single vape equals the nicotine of dozens of cigarettes. The honest answer is: nicotine uptake varies a lot by product and by user, but typical nicotine exposure for a vaper and for a smoker can be similar.

    A packet of 20 cigarettes contains about 200–300 mg of nicotine (10–15 mg per cigarette), but only a small fraction is absorbed — roughly 1–1.5 mg per cigarette, or 20–30 mg per pack. In the UK the legal limit for e-liquids is 20 mg nicotine per milliliter; a 2 ml device therefore contains 40 mg, and roughly half of that may be absorbed — around 20 mg. That’s comparable to the nicotine absorbed from a pack of cigarettes. How long a vape lasts depends on how heavily someone vapes: a moderate user might get one to two days of use from a disposable, similar to a pack of cigarettes; light users might stretch it to a week; heavy users can finish one in a day.

    Overall, average daily nicotine intake is similar between many e-cigarette users and smokers, although peak blood nicotine levels from vaping tend to be lower than from a cigarette.

    Are e-cigarettes harmful during pregnancy?

    Headlines sometimes claim vaping in pregnancy is as dangerous as smoking. Much of this reporting rests on limited animal studies or low-quality human studies. For example, a small mouse study exposed a handful of pregnant mice to nicotine vapor and found developmental differences in offspring — but extrapolating from that tiny animal experiment to humans is tenuous.

    Human studies on vaping in pregnancy are mostly low quality and give mixed results. Some comparisons show no clear difference in birth outcomes between vapers and non-users; others show no clear difference between vapers and smokers — an inconsistent picture that reflects poor study design. Nicotine can cross the placenta and may affect fetal development, so it’s plausible vaping raises some risks compared to using no nicotine at all. But because e-cigarettes lack many of the harmful combustion products in cigarettes, we should expect vaping to be less risky than smoking during pregnancy.

    If pregnant people can quit nicotine entirely, that’s best. If quitting completely proves impossible, switching from smoking to vaping is likely to be less harmful than continuing to smoke.

    Does vaping cause “popcorn lung”?

    “Popcorn lung” — bronchiolitis obliterans — became a public concern because diacetyl, a flavoring once used in microwave popcorn factories, was linked to lung damage in workers. Diacetyl was also used in some e-liquid flavorings, prompting fears e-cigarettes would cause the same disease. But there have been no reported cases of popcorn lung among vapers, and cigarette smokers are exposed to much higher diacetyl levels than vapers yet haven’t shown cases attributable to it. Diacetyl has been banned in many countries for e-liquids. Overall, the evidence linking vaping to popcorn lung is weak.

    Are e-cigarettes an effective quitting tool?

    Many smokers want to quit but struggle to do so. The research suggests e-cigarettes are the most effective tool currently available.

    Independent reviews, including recent Cochrane evidence, found high-certainty evidence that people using e-cigarettes are more likely to stop smoking than those using other nicotine replacement therapies (patches, gum). There is moderate evidence that nicotine-containing e-cigarettes are more effective than non-nicotine versions.

    In Britain, quit rates have risen over the past decade alongside the rapid rise of vaping. More than half of British smokers who quit in the last five years reported using e-cigarettes in their final successful attempt — roughly 2.4 million people. Many ex-smokers still use vapes; some have also quit vaping. E-cigarettes are not the only factor in higher quit rates, but they have likely contributed.

    One caveat: if someone both vapes and keeps smoking the same number of cigarettes, their health doesn’t improve. The benefit comes when vaping replaces cigarettes or significantly reduces smoking.

    What do current smokers think about vaping?

    Perceptions matter. Surveys show ex-smokers and current smokers who vape are more likely to say vaping is less harmful than smoking. But current smokers who do not vape — either never tried or tried and stopped — tend to believe e-cigarettes are as harmful or more harmful than cigarettes. That perception gap is important because many smokers who might benefit from switching to vaping avoid it due to safety worries or reluctance to substitute one addiction for another. Around a third cite safety concerns or fear of swapping addictions; another 13% doubt vaping would help them quit. In short, many smokers avoid trying e-cigarettes for reasons that contradict much of the scientific evidence.

    How common is vaping among people who have never smoked?

    In Great Britain about 10% of adults vape — roughly 4.7 million people. Most vapers are current or former smokers. There are about 300,000 vapers who have never smoked, roughly 1% of never-smokers. That’s a small share today, but as overall smoking declines and younger generations age, the proportion of vapers who never smoked could grow.

    How common is vaping among young people, and is it a gateway to smoking?

    Concerns about youth vaping are legitimate. Most people who become addicted to smoking start as teenagers, and younger age groups vape more than older ones: nearly 30% of 16–24-year-olds report vaping at least occasionally, compared to much lower shares in older groups.

    Is vaping a gateway to cigarettes? At the individual level, young people who vape are more likely to later try smoking than young people who don’t vape. But that association does not prove causation: young people prone to risk-taking or addiction may be more likely both to vape and later to smoke. Some reviews find very low-certainty evidence that, at the population level, increased vaping has coincided with declines in youth smoking.

    Population data give useful context. Despite rising youth vaping, smoking rates among teenagers in England and the US have continued to fall sharply in recent decades. In England, only a few percent of 15-year-olds now smoke regularly, a dramatic decrease from past decades. These trends suggest that, so far, youth vaping has not led to large increases in youth cigarette smoking, though the modest risk that vaping increases nicotine exposure among teens who would never have smoked remains a public-health concern.

    Balancing benefits and risks

    E-cigarettes can meaningfully help adult smokers quit and are substantially less harmful than smoking. Yet vaping is not risk-free, nicotine is addictive, and youth uptake is worrying. Policymakers face the difficult task of promoting e-cigarettes as an effective cessation tool for adults who smoke while limiting access and appeal to young people and never-smokers.

    Smoking remains uniquely harmful: it’s the leading risk factor for early death in many countries and causes more than six million deaths a year globally. The mistaken belief that vaping is as bad as smoking means many smokers miss an effective way to quit. Closing that perception gap could save lives.

    Acknowledgments
    Thanks to Max Roser, Edouard Mathieu, Simon van Teutem, Fiona Spooner for feedback, and Marwa Boukarim for work on visualizations.


    This article was adapted from an original report published on ourworldindata.org. All rights belong to the original publisher.

  • Stolen Car Plows Into Tempe Smoke Shop in Smash-and-Grab

    ABC15 Arizona reports that a stolen vehicle was used in a smash-and-grab at a Tempe smoke shop. Authorities are investigating the incident, and no further details have been released at this time.